Amrutanjan Health Care has informed that a meeting of the Board of Directors is scheduled to be held on August 11, 2016 to consider and approve the Unaudited Standalone Financial Results together with Limited Review Report of the Auditors for the quarter ending June 30, 2016; Merger of the Wholly-owned Subsidiary, Amrutanjan Pharmaessence with Amrutanjan Health Care. In view of the above, the trading window for dealing in the securities of the Company is closed for the Specified Persons (Directors & Designated Employees) from August 04, 2016 to August 15, 2016 as per Company’s Code of Conduct to regulate, monitor and report trading by insiders pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1858.70 |
Dr. Reddys Lab | 1258.55 |
Cipla | 1559.20 |
Lupin | 2198.25 |
Zydus Lifesciences | 1004.00 |
View more.. |